Growth Metrics

Bio-Techne (TECH) EBT (2009 - 2026)

Bio-Techne's quarterly EBT came in at $71.2 million in Q1 2026, up 86.09% year-on-year from $38.3 million in Q1 2025, and up 40.25% quarter-over-quarter from $50.8 million in Q4 2025.

Bio-Techne has reported EBT for 18 years, with the latest figure at $71.2 million in Q1 2026.

  • For the quarter ending Q1 2026, EBT rose 86.09% year-over-year to $71.2 million; the trailing twelve-month figure through Mar 2026 stood at $60.3 million (down 60.34% YoY), and the FY2025 full-year result was $11.6 million, down 93.34% from the prior year.
  • EBT for Q1 2026 stood at $71.2 million, up from $50.8 million in the prior quarter.
  • The five-year high for EBT was $103.7 million in Q3 2022, with the low at -$109.7 million in Q2 2025.
  • Average EBT over 5 years is $49.6 million, with a median of $50.8 million recorded in 2025.
  • Year-over-year, EBT jumped 274.12% in 2022 and sank 456.34% in 2025.
  • Tracing TECH's EBT over 5 years: stood at $66.4 million in 2022, then plunged by 49.74% to $33.4 million in 2023, then increased by 28.42% to $42.9 million in 2024, then gained by 18.44% to $50.8 million in 2025, then jumped by 40.25% to $71.2 million in 2026.
  • The last three EBT figures came in at $71.2 million (Q1 2026), $50.8 million (Q4 2025), and $48.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -19.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.31 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.18 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 831.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 221.65 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 71.23 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 71.23 Mn
Dec 31, 2025 50.78 Mn
Sep 30, 2025 47.99 Mn
Jun 30, 2025 -109.67 Mn
Mar 31, 2025 38.27 Mn
Dec 31, 2024 42.88 Mn
Sep 30, 2024 40.17 Mn
Jun 30, 2024 30.78 Mn
Mar 31, 2024 61.08 Mn
Dec 31, 2023 33.39 Mn
Sep 30, 2023 49.56 Mn
Jun 30, 2023 88.32 Mn
Mar 31, 2023 80.20 Mn
Dec 31, 2022 66.43 Mn
Sep 30, 2022 103.72 Mn
Jun 30, 2022 79.05 Mn
Mar 31, 2022 68.77 Mn
Dec 31, 2021 86.18 Mn
Sep 30, 2021 67.38 Mn
Jun 30, 2021 -45.40 Mn
Mar 31, 2021 45.35 Mn
Dec 31, 2020 56.37 Mn
Sep 30, 2020 39.34 Mn
Jun 30, 2020 61.53 Mn
Mar 31, 2020 46.82 Mn
Dec 31, 2019 150.33 Mn
Sep 30, 2019 17.81 Mn
Jun 30, 2019 22.79 Mn
Mar 31, 2019 49.88 Mn
Dec 31, 2018 21.77 Mn
Sep 30, 2018 17.59 Mn
Jun 30, 2018 -25.29 Mn
Mar 31, 2018 24.98 Mn
Dec 31, 2017 21.73 Mn
Sep 30, 2017 22.97 Mn
Jun 30, 2017 37.85 Mn
Mar 31, 2017 31.14 Mn
Dec 31, 2016 15.19 Mn
Sep 30, 2016 27.79 Mn
Jun 30, 2016 10.44 Mn
Mar 31, 2016 42.49 Mn
Dec 31, 2015 35.37 Mn
Sep 30, 2015 31.85 Mn
Jun 30, 2015 5.85 Mn
Mar 31, 2015 38.76 Mn
Dec 31, 2014 42.56 Mn
Sep 30, 2014 34.60 Mn
Jun 30, 2014 -88.23 Mn
Mar 31, 2014 46.07 Mn
Dec 31, 2013 36.22 Mn
Sep 30, 2013 39.65 Mn
Jun 30, 2013 40.76 Mn
Mar 31, 2013 44.47 Mn
Dec 31, 2012 37.45 Mn
Sep 30, 2012 37.99 Mn
Jun 30, 2012 40.62 Mn
Mar 31, 2012 43.21 Mn
Dec 31, 2011 37.87 Mn
Sep 30, 2011 40.50 Mn
Jun 30, 2011 -88.11 Mn
Mar 31, 2011 45.38 Mn
Dec 31, 2010 37.67 Mn
Sep 30, 2010 38.95 Mn
Jun 30, 2010 -86.26 Mn
Mar 31, 2010 41.44 Mn
Dec 31, 2009 36.70 Mn
Sep 30, 2009 39.71 Mn